scholarly journals A model of an inflammatory bowel disease population-based registry: The Forlì experience (1993–2013)

2018 ◽  
Vol 50 (1) ◽  
pp. 32-36 ◽  
Author(s):  
Daniela Valpiani ◽  
Ilaria Manzi ◽  
Marina Mercuriali ◽  
Orietta Giuliani ◽  
Alessandra Ravaioli ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Population Based ◽  
Inflammatory Bowel ◽  
Population Based Registry

Sa1159 Infection-Related HospitalIzations in Patients Newly Diagnosed With Inflammatory Bowel Disease: Results From a Population-Based Registry

2015 ◽  
Vol 148 (4) ◽  
pp. S-243-S-244
Author(s):  
Wai K. Leung ◽  
Lung-Yi Mak ◽  
Wai Pan To ◽  
Kwan-Lung Michael Ko ◽  
Hai Yun Shi ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Population Based ◽  
Newly Diagnosed ◽  
Inflammatory Bowel ◽  
Population Based Registry

Novel Targets For Therapeutic Intervention in Inflammatory Bowel Disease. What is the Best Way to Assess the Safety Profile of a Drug?

2019 ◽  
Vol 25 (1) ◽  
pp. 57-63 ◽  
Author(s):  
Clara Yzet ◽  
Stacy S. Tse ◽  
Maia Kayal ◽  
Robert Hirten ◽  
Jean-Frédéric Colombel
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Evaluation Process ◽  
Population Based ◽  
Stage Of Development ◽  
Remission Rates ◽  
Safety Parameters ◽  
Post Marketing ◽  
Inflammatory Bowel

The emergence of biologic therapies has revolutionized the management of inflammatory bowel disease (IBD) by halting disease progression, increasing remission rates and improving long-term clinical outcomes. Despite these well-described benefits, many patients are reluctant to commence therapy due to drug safety concerns. Adverse events can be detected at each stage of drug development and during the post-marketing period. In this article, we review how to best assess the safety parameters of new IBD medications, from the earliest stage of development to population-based registries, with a focus on the special populations often excluded from the evaluation process.

scholarly journals Incidence of inflammatory bowel disease in the province of Styria, Austria, from 1997 to 2007: A population-based study

2013 ◽  
Vol 7 (1) ◽  
pp. 58-69 ◽  
Author(s):  
W. Petritsch ◽  
S. Fuchs ◽  
A. Berghold ◽  
G. Bachmaier ◽  
C. Högenauer ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Population Based ◽  
Population Based Study ◽  
Inflammatory Bowel

Su1895 - Pregnancy Outcomes in Women with Inflammatory Bowel Disease: A 10-Year Nationwide Population-Based Cohort Study

2018 ◽  
Vol 154 (6) ◽  
pp. S-624
Author(s):  
Han Hee Lee ◽  
Bo-In Lee ◽  
Kang-Moon Lee ◽  
Jin Su Kim ◽  
Jae Myung Park ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Cohort Study ◽  
Bowel Disease ◽  
Pregnancy Outcomes ◽  
Population Based ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document